[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-364560-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-364560-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","data-driven-molecular-typing-a-new-frontier-in-esophageal-cancer-management-review","Data-Driven Molecular Typing: A New Frontier in Esophageal Cancer Management - review","","Esophageal squamous cell carcinoma (ESCC) is a predominant, highly lethal cancer with five-year survival below 20%, and many patients are diagnosed at advanced stages. This review consolidates current big-data approaches for molecular subtyping of ESCC, integrating multi-omics evidence including somatic genomic alterations, inherited mutations, transcriptomics, proteomics, metabolomics, and single-cell sequencing. It characterizes distinct subtypes, highlights subtype-specific mutations, signaling changes, and metabolomic patterns, and links molecular types to immunotherapy and chemotherapy response, supporting biomarker discovery and personalized treatment strategies.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/data-driven-molecular-typing-a-new-frontier-in-esophageal-cancer-management-review/364560/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/data-driven-molecular-typing-a-new-frontier-in-esophageal-cancer-management-review/364560.png","ImageObject",300,407,{"name":42,"@type":43},"Oliver","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-17","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is molecular typing important for esophageal squamous cell carcinoma (ESCC)?","Question",{"text":63,"@type":64},"Most patients have advanced disease and conventional clinicopathologic typing cannot fully meet precision medicine needs. Molecular typing can uncover tumor heterogeneity and support more precise diagnosis and treatment planning.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What data types are integrated in multi-omics molecular subtyping of ESCC?",{"text":68,"@type":64},"The review highlights integration of somatic genomic alterations and inherited genetic mutations, together with transcriptomics, proteomics, metabolomics, and single-cell sequencing to define molecular subtypes.",{"name":70,"@type":61,"acceptedAnswer":71},"How do molecular subtypes relate to treatment outcomes?",{"text":72,"@type":64},"Subtype-specific genetic mutations, signaling pathway alterations, and metabolomic profiles provide biomarkers and therapeutic targets, and the review discusses links between molecular subtypes and immunotherapy efficacy, chemotherapy response, and drug development.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},364560,1790425809,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":55,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":113,"preview_page_count":33,"preview_urls":145},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Cancer Medicine  \nREVIEW  OPEN ACCESS   \nData-Driven Molecular Typing: A New Frontier in Esophageal Cancer Management  \nYue Du1  | Bianli Gu1 | Linlin Shi1 | Yong She2 | Qi Zhao2 | Shegan Gao1  \n1Henan Key Laboratory of Microbiome and Esophageal Cancer Prevention and Treatment, Henan Key Laboratory of Cancer Epigenetics, The First Affiliated Hospital (College of Clinical Medicine) of Henan University of Science and Technology, Cancer Hospital, Luoyang, Henan, China | 2State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China  \nCorrespondence: Qi Zhao ([zhaoqi@sysucc.org.cn](zhaoqi@sysucc.org.cn)) | Shegan Gao ([gsg112258@163.com](gsg112258@163.com))  \nReceived: 16 October 2024 | Revised: 9 February 2025 | Accepted: 15 February 2025  \nFunding: This work was supported by Medical Science and Technology Research Program of Henan Province (grant/award number: LHGJ20240438) .  \nKeywords: big data | esophageal squamous cell carcinoma | molecular typing | precision treatment | single-cell sequencing  \nABSTRACT  \nBackground: Esophageal squamous cell carcinoma (ESCC) is a predominant and highly lethal form of esophageal cancer, with a five-year survival rate below 20% . Despite advancements, most patients are diagnosed at advanced stages, limiting effective treatment options. Multi-omics integration, encompassing somatic genomic alterations, inherited genetic mutations, transcriptomics, proteomics, metabolomics, and single-cell sequencing, has enabled the identification of distinct molecular subtypes of ESCC.  \nMethod: This article systematically reviewed the current status of molecular subtyping of ESCC based on big data, summarized unique subtypes with differing treatment responses and prognostic outcomes.  \nResult: Key findings included subtype-specific genetic mutations, signaling pathway alterations, and metabolomic profiles, which offer novel biomarkers and therapeutic targets. Furthermore, this review discusses the link between molecular subtypes and immunotherapy efficacy, chemotherapy response, and drug development.  \nConclusion: These insights highlight the potential of omics-based molecular typing to transform ESCC management and facilitate personalized treatment strategies.  \n1 | Introduction  \nOver the years, improvements in living standards and shifts in dietary habits have coincided with a gradual increase in the incidence and mortality rates of esophageal cancer. Globally, esophageal cancer ranks seventh in incidence and sixth in mortality [1], with a 5-year survival rate of only 20%[2] . The subtle nature of esophageal cancer symptoms underscores the critical need for timely diagnosis and screening. Esophageal squamous cell carcinoma (ESCC) is the predominant histologic form of esophageal cancer, with incidence and death rates in China being higher than in other Asian and worldwide areas. Tumor heterogeneity  \n[3], driven by genetic mutations, hereditary traits, and epigenetic alterations, complicates molecular classification, contributes to variable clinical outcomes, and hampers the identification of reliable prognostic biomarkers [4] .  \nAs biological science enters the era of genome-wide big data, numerous innovative methods and concepts have emerged in treating contemporary tumors. Traditional clinicopathologic typing methods (e.g. , histologic type and depth of infiltration) cannot meet the needs of modern precision medicine. In 1991, the National Cancer Institute (NCI) introduced the concept of molecular typing of tumors [5] . Molecular typing  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2025 The Author(s). Cancer Medicine published by John Wiley & Sons Ltd.  \nCancer Medicine, 2025; 14:e70730 1 of 12  \n[https://doi.org/10.1002/cam4.70730](h","cbCailZfPWRbQ21y","https://ap.wps.com/l/cbCailZfPWRbQ21y","pdf",343118,"English","# Abstract\n## Background\n## Method\n## Result\n## Conclusion\n# Introduction\n# Subtyping of ESCC Based on Bulk Omics Data\n## Genomics of ESCC","[{\"question\":\"Why is molecular typing important for esophageal squamous cell carcinoma (ESCC)?\",\"answer\":\"Most patients have advanced disease and conventional clinicopathologic typing cannot fully meet precision medicine needs. Molecular typing can uncover tumor heterogeneity and support more precise diagnosis and treatment planning.\"},{\"question\":\"What data types are integrated in multi-omics molecular subtyping of ESCC?\",\"answer\":\"The review highlights integration of somatic genomic alterations and inherited genetic mutations, together with transcriptomics, proteomics, metabolomics, and single-cell sequencing to define molecular subtypes.\"},{\"question\":\"How do molecular subtypes relate to treatment outcomes?\",\"answer\":\"Subtype-specific genetic mutations, signaling pathway alterations, and metabolomic profiles provide biomarkers and therapeutic targets, and the review discusses links between molecular subtypes and immunotherapy efficacy, chemotherapy response, and drug development.\"}]","Data-Driven Molecular Typing: A New Frontier in Esophageal Cancer Management - review | PDF",1790158166,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/19c711bad688d810d8ed67af36db6290.webp",983,1291,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/69739523094b024267d8ca5cda667f7b.webp",982,1290,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cdebdf13174cd7d773e5787a457281f4.webp",981,1289,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cfaf4d8b48ccb6ef0cd618408c91d419.webp",980,1287]